5-113513942-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001345975.2(YTHDC2):c.-243G>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,452,740 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001345975.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
YTHDC2 | NM_022828.5 | c.47G>T | p.Gly16Val | missense_variant | 1/30 | ENST00000161863.9 | NP_073739.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
YTHDC2 | ENST00000161863.9 | c.47G>T | p.Gly16Val | missense_variant | 1/30 | 1 | NM_022828.5 | ENSP00000161863.4 | ||
YTHDC2 | ENST00000515883.5 | c.47G>T | p.Gly16Val | missense_variant | 1/17 | 1 | ENSP00000423101.1 | |||
YTHDC2 | ENST00000503857.5 | n.47G>T | non_coding_transcript_exon_variant | 1/16 | 5 | ENSP00000426644.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1452740Hom.: 0 Cov.: 31 AF XY: 0.00000139 AC XY: 1AN XY: 721820
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 30, 2024 | The c.47G>T (p.G16V) alteration is located in exon 1 (coding exon 1) of the YTHDC2 gene. This alteration results from a G to T substitution at nucleotide position 47, causing the glycine (G) at amino acid position 16 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.